CB
ALXN

CNB Bank’s Alexion Pharmaceuticals ALXN Stock Holding History

CNB Bank’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-556
Closed -$102K – 427
2021
Q2 		$102K Hold
556
– – 0.06% 187
2021
Q1 		$85K Sell
556
-63
-10% -$9.74K 0.06% 193
2020
Q4 		$97K Sell
619
-63
-9% -$8.1K 0.07% 178
2020
Q3 		$78K Sell
682
-28
-4% -$3.02K 0.07% 180
2020
Q2 		$80K Sell
710
-366
-34% -$38.9K 0.07% 184
2020
Q1 		$97K Sell
1,076
-869
-45% -$85.3K 0.1% 162
2019
Q4 		$210K Sell
1,945
-490
-20% -$52.4K 0.18% 138
2019
Q3 		$239K Sell
2,435
-1,015
-29% -$114K 0.22% 116
2019
Q2 		$452K Sell
3,450
-717
-17% -$92.4K 0.39% 80
2019
Q1 		$564K Buy
4,167
+780
+23% +$97K 0.29% 66
2018
Q4 		$330K Buy
3,387
+609
+22% +$72K 0.21% 84
2018
Q3 		$386K Sell
2,778
-103
-4% -$12.9K 0.22% 79
2018
Q2 		$357K Buy
2,881
+390
+16% +$45.6K 0.21% 81
2018
Q1 		$278K Buy
2,491
+1,236
+98% +$148K 0.16% 93
2017
Q4 		$150K Buy
+1,255
New +$153K 0.09% 108

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

CNB Bank's ALXN Position: Q3 2021 in Review

CNB Bank sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 556 shares — an estimated $102K sold.

CNB Bank first reported a position in ALXN in Q4 2017 and held it in 15 quarters. The position peaked at $564K in Q1 2019. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • CNB Bank reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • CNB Bank sold 556 Alexion Pharmaceuticals shares in Q3 2021, an estimated $102K.
  • CNB Bank first reported a position in Alexion Pharmaceuticals in Q4 2017 and held it in 15 quarters.
  • CNB Bank's Alexion Pharmaceuticals position peaked at $564K in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on CNB Bank's 13F filing for Q3 2021, filed 2 Nov 2021.